Radiation therapy for medically inoperable stage I and II non-small cell lung cancer Journal Article


Authors: Armstrong, J. G.; Minsky, B. D.
Article Title: Radiation therapy for medically inoperable stage I and II non-small cell lung cancer
Abstract: The published results of primary radiation therapy for early stage NSCLC, indicate that it is a reasonable alternative in patients with medical contraindications or who refuse surgery, resulting in acceptable morbidity, local control, and survival rates. There is no conclusive evidence that EMI is of benefit. Consequently treatment with involved field alone, may be considered when there is no evidence of hilar involvement, or when it is necessary to limit the volume of lung tissue irradiated. Although the data are not conclusive, there is evidence to suggest that the total dose of radiation delivered to the primary should be sufficient to eradicate gross disease (60 Gy or higher). Such doses result in high response rates particularly for T1 tumors. There is also an indication that complete responders have better survival than other patients, suggesting that radiotherapeutic strategies to enhance tumor eradication may improve survival. © 1989.
Keywords: survival; review; neoplasm staging; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; lung cancer; human; priority journal
Journal Title: Cancer Treatment Reviews
Volume: 16
Issue: 4
ISSN: 0305-7372
Publisher: Elsevier Inc.  
Date Published: 1989-12-01
Start Page: 247
End Page: 255
Language: English
DOI: 10.1016/0305-7372(89)90044-3
PUBMED: 2561593
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 14 April 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bruce Minsky
    306 Minsky